Burden of illness and healthcare resource utilization for chronic obstructive pulmonary disease in Ontario

Summary

Client: IQVIA Solutions Canada Inc

Project ID: P2024-214 / 2025 0970 396 000

Research Question/Objectives: Chronic obstructive pulmonary disease (COPD) is a disease characterized by progressive dyspnea, chronic cough, and/or excess sputum production. COPD is the seventh leading contributor to morbidity and the third leading cause of death worldwide in 2019.

Objectives:

Primary objectives:

1. Characterize patients with COPD at the time of their first exacerbation on demographic and clinical characteristics
2. Describe the HCRU incurred by patients with COPD during a 12-month period after an exacerbation (i.e., moderate exacerbation and severe exacerbation).

Secondary objectives:

1. Stratify the primary objectives by exacerbation type (i.e., moderate exacerbation versus severe exacerbation)
2. Stratify total HCRU incurred by patients with COPD during a 12-month period after an exacerbation (i.e., moderate exacerbation and severe exacerbation) pre- and post- COVID (based on exacerbation index date).

Exploratory objective:

1. Pending the sample size aged 40-65, the results may be stratified by <65, >65 or those <65 may be excluded from the cohort.

Status: In Progress